Skip to main content
Membership NewsMembership News Archive

ADLM and the US trade mission

Can you join us on Thursday 7 March at 10.30 for a special on-line meeting about the ADLM exhibition and a trade mission to two US centres? BIVDA and GAMBICA members are being offered the opportunity to participate in the ADLM exhibition which takes place in Chicago from 28 July to 1 August. ADLM was formerly known as the AACC…
Ben Kemp
March 6, 2024
Membership NewsMembership News Archive

Reminder: Register for BIVDA’s AGM on 20 March

A reminder to members to sign-up for BIVDA’s 2024 Annual General Meeting, taking place at 11.00am on 20 March 2024 at One Great George Street, London. On the day, BIVDA will be launching our 2024-2027 strategy, themed “Diagnostics: the heart of healthcare.” This is a great opportunity to network with fellow BIVDA members and policymakers, and hear from industry experts,…
Ben Kemp
March 6, 2024
Membership NewsMembership News Archive

Rare Diseases Action Plan: Briefing

Last week marked the release of the Government’s Rare Diseases Action Plan for 2024. The Plan looks at the achievements in tackling rare diseases over the previous year and establishes future goals to enable fundamental change. This is the third iteration of England’s plan, having been published annually since 2022. Pertaining to the diagnosis of rare diseases, the Government listed…
Ben Kemp
March 6, 2024
Membership NewsMembership News Archive

MHRA MedTech Regulatory Reform Webinar: Briefing

The MHRA yesterday outlined planned significant updates to UK Medical Device Regulations. The changes include updating the scope of the Regulations, changing the classification of in-vitro diagnostics devices (IVD) and change the Essential Requirements. The definition of 'in-vitro diagnostic devices' will now include software and devices intended for diagnosing physical or mental impairments, predispositions to medical conditions or diseases, and…
Ben Kemp
March 6, 2024
ConsultationsConsultations Archive

Addition of quadruple test to Edwards’ syndrome screening pathway

The UK National Screening Committee (UK NSC) endorses the offer of antenatal screening for Edwards’ syndrome as part of the NHS fetal anomaly screening pathway. The UK NSC is consulting on a rapid review of modelled data conducted by NHS England. This data suggests that the quadruple screening test, which is offered to pregnant women who miss the first trimester combined screening test, should be…
Ben Kemp
February 21, 2024
HighlightsHighlights Archive

Media Monitoring: 15 – 21 February

Understanding the lived-experience and support-needs of people living with antimicrobial resistance in the UK through interpretative phenomenological analysis An important examination of the effects of AMR on patients In the UK nearly 54,000 infections were caused by serious resistant bacteria in 2022 Emerging evidence indicates that patients lack an understanding of what AMR is, yet they also report significant psychological…
Ben Kemp
February 21, 2024
HighlightsHighlights Archive

New project to ‘unlock prevention’ within ICSs

The NHS Confederation, University of Stirling, University of Southampton and Newton have launched a research project to understand the barriers to unlocking at-scale preventative health and care within integrated care systems (ICSs). The research will map prevention work being undertaken at system, place and neighbourhood levels and the barriers that exist to collaborative prevention. The research team, professors Paul Cairney…
Ben Kemp
February 21, 2024
HighlightsHighlights Archive

DNA analysis could explain increased risk of prostate cancer in Black men

Scientists have discovered genetic differences which explain why Black men are more prone to prostate cancer compared to other ethnicities, leading to hopes that a test can be developed which identifies those at elevated risk. Prostate cancer is the most prevalent form of cancer among men in Britain, accounting for approximately 52,300 cases and 12,000 fatalities annually in the UK.…
Ben Kemp
February 21, 2024